Blood-brain barrier function of P-glycoprotein

Advanced Drug Delivery Reviews

Volumn 25, Issue 2-3, 1997, Pages 287-298

  Tsuji, Akira ^a   Tamai, Ikumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

ATP binding cassette; Blood brain barrier; Dynamic interface; Efflux pump; P glycoprotein

Indexed keywords

BRAIN; CELLS; DRUG PRODUCTS; INTERFACES (MATERIALS); NEUROLOGY; PHYSIOLOGY; PROTEINS;

ATP BINDING CASETTE; BLOOD BRAIN BARRIER; EFFLUX PUMP; GLYCOPROTEINS; XENOBIOTICS;

DRUG THERAPY;

CYCLOSPORIN A; DEXAMETHASONE; DIGOXIN; DOXORUBICIN; GLYCOPROTEIN P; IVERMECTIN; RHODAMINE 123; VALSPODAR; VERAPAMIL; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; XENOBIOTIC AGENT;

ARTICLE; BLOOD BRAIN BARRIER; DRUG DISTRIBUTION; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 0343247810     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00504-8     Document Type: Review

References (57)

1. Pardridge, W.M. (1983) Brain metabolism: A perspective from the blood-brain barrier. Physiol. Rev. 63, 1481-1535.
2. Comford, E.M. (1985) The blood-brain barrier, a dynamic regulatory interface. Mol. Physiol. 7, 219-260.
3. Levin, V.A. (1980) Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J. Med. Chem. 23, 682-684.
4. Pardridge, W.M., Triguero, D., Yang, J. and Cancilla, P.A. (1990) Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. J. Pharmacol. Exp. Ther. 253, 884-891.
5. Pardridge, W.M. (1995) Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug. Deliv. Rev. 15, 5-36.
6. Zlokovic, B.V. (1995) Cerebrovascular permeability to peptides: Manipulations of transport systems at the blood-brain barrier. Pharm. Res. 12, 1395-1406.
7. Banks, W.A., Kastin, A.J. and Barrera, C.M. (1991) Delivering peptides to the central nervous system: Dilemmas and strategies. Pharm. Res. 8, 1345-1350.
8. Tamai, I. and Tsuji, A. (1996) Pharmacokinetics in drug delivery systems: Drug delivery through the blood-brain barrier. Adv. Drug. Deliv. Rev. 19, 401-424.
9. Tsuji, A., Terasaki, T., Takabatake, Y., Tenda, Y., Tamai, I., Yamashima, T., Moritani, S., Tsuruo, T. and Yamashita, J. (1992) P-Glycoprotein as the drug efflux pump in primary cultured brain capillary endothelial cells. Life Sci. 51, 1427-1437.
10. Tatsuta, T., Naito, M., Oh-hara, T., Sugawara, I. and Tsuruo, T. (1992) Functional involvement of P-glycoprotein in blood-brain barrier. J. Biol. Chem. 267, 20383-20391.
11. Greenwood, J. (1992) Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro. J. Neuroimmunol. 39, 123-132.
12. Hegmann, E.J., Bauer, H.C. and Kerbel, R.S. (1992) Expression and functional activity of P-glycoprotein in cultured cerebral capillary endothelial cells. Cancer Res. 52, 6969-6975.
13. Biedler, J.L. and Riehm, H. (1970) Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 30, 1174-1184.
14. Juliano, R.L. and Ling, V. (1976) Surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162.
15. Bradley, G., Juranka, P.F. and Ling, V. (1989) Mechanism of multidrug resistance. Biochim. Biophys. Acta 948, 87-128.
16. Skovsgaard, T. (1978) Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cell. Cancer Res. 38, 4722-4727.
17. Gross, P., Neriah, Y.B., Croop, J.M. and Housman, D.E. (1986) Isolation and expression of complementary DNA that confers multidrug resistance. Nature 323, 728-731.
18. Safa, A.R. (1989) Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil. Proc. Natl. Acad. Sci. U.S.A. 85, 7187-7191.
19. Tamai, I. and Safa, A.R. (1991) Azidopine noncompetitively interacts with vinblastine and cydosporin A binding to P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 266, 16796-16800.
20. Beck, W.T. and Qiam, X.-D. (1992) Photoaffinity substrates for P-glycoprotein. Biochem. Pharmacol. 43, 89-93.
21. Endicott, J.A. and Ling, V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58, 137-171.
22. Gross, R, Raymond, M., Bell, J. and Housman, D. (1988) Cloning and characterization of a second member of the mouse mdr gene family. Mol. Cell. Biol. 8, 2770-2778.
23. Silverman, J.A., Raunio, H., Gant, T.W. and Thorgeirsson, S.S. (1991) Cloning and characterization of the rat multidrug resistance (mdr) gene family. Gene 106, 229-236.
24. Brown, R C., Thorgeirsson, S.S. and Silverman, J. A. (1993) Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res. 21, 3885-3891.
25. Smit, J.J., Schinkel, A.H., Oude Elferink, R.P.J., Groen, A.K., Wagenaar, E., van Deemter, L., Mol, C.A.A.M., Ottenhoft, R., van der Lugt, N.M.T., van Roon, M.A., van der Valk, M.A., Offerhaus, G.J.A., Berns, A.J.M. and Borst, P. (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462.
26. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M. (1987) Cellular localization of the multidrug-resistance gene P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 84, 7735-7738.
27. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M.C. (1989) Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J. Histochem. Cytochem. 37, 159-164.
28. Cordon-Cardo, C., O'Brien, J.P., Casals, D., Rittaman-Grauer, L., Biedler, J.L., Melamed, M.R. and Bertino, J.R. (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. U.S.A. 86, 695-698.
29. Watanabe, T. Miyauchi, S., Sawada, Y., Iga, T., Hanano, M., Inaba, M. and Sugiyama, Y. (1992) Kinetic analysis of hepatobiliary transport of vincristine. J. Hepatol. 16, 77-88.
30. Tanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T. and Hon. R. (1992) Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J. Pharmacol. Exp. Ther. 263, 840-845.
31. Sugawara, I., Hamada, H., Tsuruo, T. and Mon, S. (1990) Specialized localization of P-glycoprotein recognized by MRK16 monoclonal antibody in endothelial cells of the brain and the spinal cord. Jpn. J. Cancer Res. 81, 727-730.
32. Jette, L., Tetu, B. and Beliveau, R. (1993) High levels of P-glycoprotein detected in isolated brain capillaries. Biochim. Biophys. Acta 1150, 147-154.
33. Audus, K.L. and Borchardt, R.T. (1986) Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm. Res. 3, 81-87.
34. Biegel, D., Spencer, D.D. and Pachter, J.S. (1995) Isolation and culture of human brain microvessel endothelial cells for the study of blood-brain barrier properties in vitro. Brain Res. 692, 183-189.
35. Barrand, M.A., Robertson, K.J. and von Weikersthal, S.F. (1995) Comparison of P-glycoprotein expression in isolated rat brain microvessels in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta. FEBS Lett. 374, 179-183.
36. Joly, B., Fardel, O., Cecchelli, R., Chesne, C., Puozzo, C. and Guillouzo, A. (1995) Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model. Toxicol. In Vitro 9, 357-364.
37. Lechardeur, D., Schwartz, B., Paulin, D. and Scherman, D. (1995) Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. Exp. Cell Res. 220, 161-170.
38. Cefalu, W.T. and Pardridge, W.M. (1985) Restrictive transport of a lipid-soluble peptide (cyclosporin) through the blood-brain barrier. J. Neurochem. 45, 1054-1956.
39. Begley, D.J., Squires, L.K., Zlokovic, B.V., Mitrovic, D.M., Hughes, C.C., Revest, PA. and Greenwood, J. (1990) Permeability of the blood-brain barrier to the immunosuppressive peptide cyclosporin A. J. Neurochem. 55, 1222-1230.
40. Tamai, I. and Safa, A.R. (1990) Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug resistant cells. J. Biol. Chem. 265, 16509-16513.
41. Tsuji, A., Tamai, I., Sakata, A., Tenda, Y. and Terasaki, T. (1993) Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. Biochem. Pharmacol. 46, 1096-1099.
42. Shirai, A., Naito, M., Tatsuta, T., Dong, J., Hanaoka, K., Mikami, K., Oh-hara, T. and Tsuruo, T. (1994). Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim. Biophys. Acta 1222, 400-404.
43. Higgins, C.F. (1992) ABC transporters: From microorganisms to man. Ann. Rev. Cell Biol. 8, 67-113.
44. Hyde, S.C., Emsley, P, Hartshorn, M.J., Mimmack, M.M., Gileadi, U., Pearce, S.R., Gallagher, M.P, Gill, D.R., Hubbard, R.E. and Higgins, C.F. (1990) Structure and model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346, 362-365.
45. Demolombe, S. and Escande, D. (1996) ATP-binding cassette proteins as targets for drug discovery. TiPS 17, 273-275.
46. Ohnishi, T., Tamai, I., Sakanaka, K., Sakata, A., Yamashima, T., Yamashita, J. and Tsuji, A. (1995) In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem. Pharmacol. 49, 1541-1544.
47. Colombo, T., Zucchetti, M. and D'Incalci, M. (1994) Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats. J. Pharmacol. Exp. Ther. 269, 22-27.
48. Jette, L., Murphy, G., Lecleic, J.-M. and Beliveau, R. (1995) Interaction of drugs with P-glycoprotein in brain capillaries. Biochem. Pharmacol. 50, 1701-1709.
49. Sakata, A., Tamai, I., Kawazu, K., Deguchi, Y., Ohnishi, T., Saheki, A. and Tsuji, A. (1994) In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem. Pharmacol. 48, 1989-1992.
50. Schinkel, A.H., Smit, J.J.M., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A.A.M, van der Valk, MA., Robanus-Maandag, E.C., te Riele, H.P.J., Berns, A.J.M. and Borst, P (1994) Disruption of the mouse mdrla P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502.
51. Wang, Q., Yang, H., Miller, D.W. and Elmquist, W.F. (1995) Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: An in vivo microdialysis study in freely moving rats. Biochem. Biophys. Res. Commun. 211, 719-726.
52. Chikhale, E.G., Burton, PS. and Borchardt, R.T. (1995) The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J. Pharmacol. Exp. Ther. 273, 298-303.
53. Banks, W.A. and Kastin, A.J. (1994) Brain-to-blood transport of peptides and the alcohol withdrawal syndrome. N.Y. Acad. Sci., 739, 108-118.
54. Plusinelli, W.A. and Duffy, T.E. (1983) Regional energy balance in rat brain after transient forebrain ischemia. J. Neurochem. 40, 1500-1503.
55. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A.A.M. and Borst, P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96, 1698-1705.
56. Kakee, A., Terasaki, T. and Sugiyam, Y. (1995) Organic anion transport system acting as an efflux pump at the blood-brain barrier: Demonstration by a newly developed brain efflux index (BEI) method. Proc. Int. Symp. Control. Release Bioact. Mater., 15-16.
57. Pastan, I., Willingham, M.C. and Gottesman, M. (1991) Molecular manipulations of the multidrug transporter: a new role for transgenic mice. FASEB J., 5, 2523-2528.